Home > Insider Trading > Filing (0000903423-15-000387)

Filing Details

Accession Number:: 0000903423-15-000387
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-15 20:09:44
Reporting Period:: 2015-06-11

Filing Date:: 2015-06-15
Accepted Time:: 2015-06-15 20:09:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1488613	Foundation Medicine Inc.	FMI	Services-Medical Laboratories (8071)	271316416

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585001	Krishna Yeshwant	1600 Amphitheatre Parkway Mountain View CA 94043		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-06-11	15,734	$35.14	168,126	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2015-06-12	53,645	$33.72	114,481	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2015-06-15	114,481	$32.33	0	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.90 to $35.42, inclusive. The Reporting Person undertakes to provide to Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $35.26, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.71, inclusive.
These shares were directly held by Google Ventures 2011, L.P. The general partner of Google Ventures 2011, L.P. is Google Ventures 2011 GP, L.L.C. The Reporting Person is a partner at an affiliate of Google Ventures 2011 GP, L.L.C. and disclaims beneficial ownership of all shares except to the extent of his pecuniary interest, if any, therein.
Solely as a result of the Investor Rights Agreement filed as Exhibit 4.1 of the Form 8-K filed by Issuer with the Securities and Exchange Commission on January 12, 2015 and the Reporting Person's position as a partner at an affiliate of Google Ventures 2011 GP, L.L.C., the Reporting Person may have been deemed to have beneficial ownership of the (a) 20,604,288 shares directly held by Roche Holdings, Inc., an indirect wholly owned subsidiary of Roche Holding Ltd ("Roche" and together with Roche Holdings, Inc. and Roche Finance Ltd, the "Roche Entities"), (b) 414,823 shares directly held by Roche Finance Ltd, a wholly owned subsidiary of Roche and (c) shares previously held by Third Rock Ventures, L.P. ("TRV"). Google Ventures 2011, L.P. no longer holds shares of the Issuer and, accordingly, the Reporting Person may not be deemed to beneficially own shares directly held by the Roche Entities and TRV. The Reporting Person disclaims beneficial ownership of any shares of Issuer held by any of the Roche Entities and TRV.